SCHEMBL4692676

SCHEMBL4692676

Cc1ccc(NCCCN2CC3CN(C(=O)c4cccc(C)c4Cl)CC3C2)cc1Cl

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.45
CCR5 P51681 8/20 0.42
ALDH1A1 P00352 4/20 0.41
MAPT P10636 3/20 0.41
GAA P10253 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MGLL Q99685 2/20 0.39
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
AGTR1 P30556 1/20 0.38
RAB9A P51151 1/20 0.38
KCNK3 O14649 1/20 0.38
KCNK9 Q9NPC2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4694356 0.94 P2RX7 (0.43) P2RX7CCR5ALDH1A1MAPTGAA
SCHEMBL4694387 0.93 GAA (0.41) P2RX7CCR5ALDH1A1MAPTGAA
SCHEMBL4691872 0.93 HCRTR1 (0.47) CCR5ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4692889 0.92 MAPT (0.45) CCR5ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4691764 0.91 CCR5 (0.42) CCR5ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL3284097 0.91 CCR5 (0.41) CCR5ALDH1A1MAPTGAASMN1; SMN2
SCHEMBL4692218 0.91 CCR5 (0.42) P2RX7CCR5ALDH1A1MAPTGAA
SCHEMBL4693334 0.90 ALDH1A1 (0.45) P2RX7CCR5ALDH1A1MAPTGAA
SCHEMBL4694025 0.90 P2RX7 (0.48) P2RX7
SCHEMBL4691305 0.90 MAPT (0.42) CCR5ALDH1A1MAPTGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP claimed
EP-1761542-B1 OCTAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AN THEIR USE AS ANTIVIRAL AGENTS HOFFMANN LA ROCHE (CH) 2008-01-02 EP disclosed